NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 298 filers reported holding NEOGENOMICS INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,679,000 | -32.9% | 206,021 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $2,503,000 | -67.9% | 206,021 | -9.8% | 0.00% | -60.0% |
Q4 2021 | $7,797,000 | -35.1% | 228,506 | -8.2% | 0.01% | -44.4% |
Q3 2021 | $12,014,000 | +15.3% | 249,043 | +8.0% | 0.01% | +12.5% |
Q2 2021 | $10,420,000 | -10.2% | 230,695 | -4.1% | 0.01% | -11.1% |
Q1 2021 | $11,602,000 | -8.2% | 240,554 | +2.5% | 0.01% | -10.0% |
Q4 2020 | $12,641,000 | +43.5% | 234,794 | -1.7% | 0.01% | +25.0% |
Q3 2020 | $8,808,000 | +22.0% | 238,776 | +2.5% | 0.01% | +14.3% |
Q2 2020 | $7,218,000 | +21.6% | 232,976 | +8.3% | 0.01% | 0.0% |
Q1 2020 | $5,937,000 | -44.0% | 215,027 | -40.7% | 0.01% | -30.0% |
Q4 2019 | $10,603,000 | +155.5% | 362,512 | +67.0% | 0.01% | +150.0% |
Q3 2019 | $4,150,000 | +58.9% | 217,044 | +82.3% | 0.00% | +33.3% |
Q2 2019 | $2,612,000 | -2.1% | 119,043 | -8.7% | 0.00% | 0.0% |
Q1 2019 | $2,669,000 | +97.4% | 130,447 | +21.6% | 0.00% | +50.0% |
Q4 2018 | $1,352,000 | -26.5% | 107,244 | -10.5% | 0.00% | 0.0% |
Q3 2018 | $1,839,000 | +67.0% | 119,830 | +42.7% | 0.00% | 0.0% |
Q2 2018 | $1,101,000 | +46.0% | 83,969 | -9.1% | 0.00% | +100.0% |
Q1 2018 | $754,000 | -7.8% | 92,377 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $818,000 | -27.7% | 92,377 | -9.1% | 0.00% | -50.0% |
Q3 2017 | $1,132,000 | +40.1% | 101,663 | +12.7% | 0.00% | +100.0% |
Q2 2017 | $808,000 | +18.5% | 90,200 | +4.3% | 0.00% | 0.0% |
Q1 2017 | $682,000 | -12.9% | 86,500 | -5.4% | 0.00% | 0.0% |
Q4 2016 | $783,000 | +9.4% | 91,400 | +4.9% | 0.00% | 0.0% |
Q3 2016 | $716,000 | +2.3% | 87,100 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $700,000 | +20.1% | 87,100 | +0.7% | 0.00% | 0.0% |
Q1 2016 | $583,000 | -14.4% | 86,500 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $681,000 | +37.3% | 86,500 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $496,000 | +6.0% | 86,500 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $468,000 | -0.6% | 86,500 | -27.9% | 0.00% | 0.0% |
Q1 2015 | $471,000 | 0.0% | 119,945 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $471,000 | -24.6% | 119,945 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $625,000 | +117.8% | 119,945 | +38.7% | 0.00% | – |
Q2 2014 | $287,000 | -0.7% | 86,500 | 0.0% | 0.00% | – |
Q1 2014 | $289,000 | – | 86,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |